Search Results for "Bronchitol To Treat Bronchiectasis"
Matching Channels
Anti-viral peptides are used to treat infections such as HIV and AIDS, influenza incl. H5N1 strains, hepatitis C virus infections (HCV). Anti-bacterial peptides are used to treat infectiou...
What is GENOTROPIN? GENOTROPIN (somatropin [rDNA origin] for injection) is a growth hormone treatment. It is an exact copy of the natural growth hormone that our bodies make. The main difference i...
Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...
Anti-CD22 antibody-based constructs used to treat B-cell mediated malignancies and rheumatoid arthritis.
Matching News
FDA reviewers question Bronchitol efficacy
FDA reviewers said efficacy results for Bronchitol mannitol from Pharmaxis Ltd. (ASX:PXS; Pink:PXSLY) are "inconsistent," as the product met the primary endpoint in only one of two Phase III trials to...
Pharmaxis receives Bronchitol complete response
Pharmaxis Ltd. (ASX:PXS; Pink:PXSLY) received a complete response letter from FDA for an NDA for Bronchitol mannitol to improve pulmonary function in cystic fibrosis (CF) patients six years of age and...
FDA to review Bronchitol for CF
FDA accepted for review an NDA from Pharmaxis Ltd. (ASX:PXS; Pink:PXSLY) for Bronchitol mannitol to treat cystic fibrosis (CF) in patients six years of age or older to improve pulmonary function. The...
Azithromycin could be an option for bronchiectasis patients
Azithromycin reduces the frequency of exacerbations in non-cystic fibrosis bronchiectasis patients, according to research published...
FDA planning workshops on bronchiectasis, kidney transplantation
FDA announced two indication-specific public workshops on Wednesday, including one on Sept. 7 to discuss trial designs for antibacterial drugs to treat non-cystic fibrosis bronchiectasis. On Sept. 10-...
In addition to the conditions listed by Chapman,1 outpatient parenteral antimicrobial therapy (OPAT) has potential application for infective exacerbations of non-cystic fibrosis bronchiectasis, where....
Pharmaxis tumbles on FDA rejection of Bronchitol in CF
Given the unanimous snub it got in January from a US FDA panel of advisers, it came as little surprise regulators rejected Pharmaxis' new drug application for Bronchitol, an experimental dry-powder...
Bronchiectasis Grading System Identifies At-Risk Patients
A 7-point scale has been developed to evaluate disease severity in patients with noncystic fibrosis bronchiectasis. Medscape Medical News
Matching PubMed Articles
Treatment of not with cystic fibrosis associated forms bronchiectasis (non-CF bronchiectasis).
Bronchiectasis has become more rarely because of the development of antibiotic therapy and vaccination. At present the great majority of bronchiectasis is more likely caused by congenital disorders th...
Effect of inhaled dry powder mannitol on mucus and its clearance.
Insufficient hydration at the airway surface can make mucus adherent and poorly cleared. Cough, the major mechanism of mucus clearance in disease, is ineffective when mucus is adhesive. Inhaled mannit...
QUANTITATIVE AND QUALITATIVE COMPUTED TOMOGRAPHIC CHARACTERISTICS OF BRONCHIECTASIS IN 12 DOGS.
Bronchiectasis is an irreversible dilatation of the bronchi resulting from chronic airway inflammation. In people, computed tomography (CT) has been described as the noninvasive gold standard for diag...
Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma.
To cite this article: Menzies D, Holmes L, McCumesky G, Prys-Picard C, Niven R. Aspergillus sensitization is associated with airflow limitation and bronchiectasis in severe asthma. Allergy 2011; DOI:...
Macrolide antibiotics have been shown beneficial in cystic fibrosis (CF) and diffuse panbronchiolitis, and earlier findings also suggest a benefit in non-CF bronchiectasis.
